Early Prognostic Factors for Remission Achievement at Etanercept Therapy in Patients with Juvenile Idiopatic Arthritis Without Systematic Manifestations: Prospective Cohort Study

Early Prognostic Factors for Remission Achievement at Etanercept Therapy in Patients with Juvenile Idiopatic Arthritis Without Systematic Manifestations: Prospective Cohort Study

Background. Prognosis of therapy results of patients with the juvenile idiopatic arthritis (JIA) without systematic manifestations is the precondition of their treatment efficiency enhancement.Objective. Our aim was to establish early predictors for remission achievement in patients with JIA without...

Full description

Bibliographic Details
Main Authors: Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Dariya D. Vankova, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2019-04-01
Series:Вопросы современной педиатрии
Subjects:
дети
ювенильный идиопатический артрит
терапия
предикторы
факторы риска
генно-инженерный биологический препарат
этанерцепт
побочные эффекты
Online Access:https://vsp.spr-journal.ru/jour/article/view/2023

Internet

https://vsp.spr-journal.ru/jour/article/view/2023

Similar Items